Skip to main content
. 2019 Nov 15;58(22):3219–3225. doi: 10.2169/internalmedicine.2849-19

Table 2.

Laboratory, UCG and CPET Data.

Laboratory data UCG data
DGLA (mg/mL) 37.4±14.5 (13.6-79.1) LVIVS (mm) 10.1±2.1 (6-16)
AA (mg/mL) 176.6±42.7 (96.9-269.1) LVPW (mm) 10.4±1.8 (7-15)
DGLA+AA (mg/mL) 211.9±55.3 (72-323.2) LVDD (mm) 62.1±10.7 (43-92)
EPA (mg/mL) 46.7±29.1 (8-155.7) LVDS (mm) 53.7±11.4 (55-81)
DHA (mg/mL) 114.6±44.8 (10.3-208.9) LVEF (%) 29.6±9.8 (10-57)
EPA+DHA (mg/mL) 161.3±69.9 (35.7-351.1)
EPA/AA 0.27±0.16 (0.05-0.74) CPET data
(EPA+DHA/AA) 1.00±0.69 (0.18-5.00) Peak VO2 (mL/kg/min) 17.0±3.9 (8.1-29.1)
(EPA+DHA)/(DGLA+AA) 0.79±0.43 (0.14-2.92) %ppVO2 (%) 65.0±14.2 (31-90)
AA/DGLA 5.14±1.90 (1.4-10.8) VE/VCO2 slope 30.5±6.9 (19.2-50.9)
NT-pro BNP (pg/mL) 1,185.8±999.2 (109.6-4,024)
Hb (g/dL) 15.1±1.8 (10.4-18.8)
eGFR (mL/min/1.73m2) 64.3±16.2 (37.3-108.4)
TC (mg/dL) 179.4±36.9 (101.4-265)
LDL-C (mg/dL) 107.4±28.0 (61-197)
HDL-C (mg/dL) 44.3±12.2 (12-85)
TG (mg/dL) 138.4±76.8 (36-416)
HbA1c (%) 6.2±1.0 (5.2-10.1)
Alb (g/dL) 4.0±0.5 (2.3-4.7)
CRP (mg/dL) 0.29±0.48 (0.02-2.23)

Values presented as n (%) or means±SD. DGLA: dihomo-γ-linolenic acid, AA: arachidonic acid, EPA: eicosapentaenoic acid, DHA: docosahexaenoic acid, NT-pro BNP: N-terminal pro-brain natriuretic peptide, Hb: hemoglobin, eGFR: estimate glomerular filtration rate, TC: total cholesterol, LDL-C: low-density lipoprotein cholesterol, HDL-C: high-density lipoprotein cholesterol, TG: triglyceride, HbA1c: hemoglobin A1c, Alb: albumen, CRP: C-reactive protein, UCG: ultrasonic echocardiography, IVS: interventricular septum, LVPW: left ventricular posterior wall, LVDD: left ventricular internal dimension in diastole, LVDS: left ventricular diameter at end systole, EF: ejection fraction, CPET: cardiopulmonary exercise test, peak VO2: peak oxygen uptake, %ppVO2: percent predicted peak VO2, VE/VCO2 slope: regression slope relating minute ventilation to carbon dioxide output